Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases

Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases

Abstract The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19) and the ensuing worldwide pandemic. The spread of the virus has had global effects such as activity restriction, economic stagnation, and collapse...

Full description

Bibliographic Details
Main Authors: Atsunori Tsuchiya, Suguru Takeuchi, Takahiro Iwasawa, Masaru Kumagai, Takeki Sato, Satoko Motegi, Yui Ishii, Youhei Koseki, Kei Tomiyoshi, Kazuki Natsui, Nobutaka Takeda, Yuki Yoshida, Fusako Yamazaki, Yuichi Kojima, Yusuke Watanabe, Naruhiro Kimura, Kentaro Tominaga, Hiroteru Kamimura, Masaaki Takamura, Shuji Terai
Format: Article
Language:English
Published: BMC 2020-06-01
Series:Inflammation and Regeneration
Subjects:
COVID-19
SARS-CoV-2
Mesenchymal stem cells
Exosome
Cytokine storm
Acute respiratory distress syndrome
Online Access:http://link.springer.com/article/10.1186/s41232-020-00121-y

Internet

http://link.springer.com/article/10.1186/s41232-020-00121-y

Similar Items